Organization | Medical Centre Dinasty

Medical Centre Dinasty Report issue

Academic/Hospital Phase 2

Founded: Samara Russian Federation

Organization Overview

First Clinical Trial

2018

NCT03826498

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Medical Centre Dinasty | State-Financed Health Facility "Samara Regional Medical Center Dinasty"

Active Ingredients

Drugs in Phase 2 Trials (7)

allogeneic cord blood (1 trial)

allogeneic hematopoietic stem cells (Hemacord) (1 trial)

cord blood hematopoietic stem cell (2 trials)

cord blood stem cells (1 trial)

Mesenchymal Stem Cells Exosomes (2 trials)

sodium chloride (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Autism Spectrum Disorder (Phase 2)

Autistic Disorder (Phase 2)

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Cerebral Palsy (Phase 2)

Heart Failure (Phase 2)

Pneumonia (Phase 2)

Overview

Highest Phase: Phase 2
# of Trials: 8
# of Trial APIs: 7